A comprehensive peer-reviewed invited review published today in Psychedelics by Dr. Kenji Hashimoto and colleagues ...
Company backed by Sam Altman gets FDA approval to trial ‘legal ecstasy’ - Clinical trials of ‘safer MDMA’ could lead to new ...
The drug 3,4-Methylenedioxymethamphetamine (MDMA), also known as 'ecstasy', seems to produce dose-related increases in myocardial oxygen demand without an increase in the contractility of the heart.
Post-traumatic stress disorder is one of the most common mental health conditions in the world, with an estimated six out of every 100 people in the United States alone experiencing PTSD at some point ...
Only two drugs are formally approved for post-traumatic stress disorder, or PTSD, and they don’t help everyone. A lack of effective treatment options has led some patients to seek out the psychedelic ...
The legendary non-profit’s private arm, MAPS Public Benefit Corporation (MAPS PBC), announced that Frontiers in Psychiatry has published its first functional neuroimaging study evaluating how ...
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.Video above: Decriminalizing magic mushrooms, natural ...
Post-traumatic stress disorder (PTSD) is a common disorder in the general population. Risk factors for developing PTSD include being female, having a history of personal or family psychiatric disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback